Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (13)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
OEDT = EMCDDA ; L. LANIEL ; M. GANDILHON ; J. E. ADES ; A. CUNNINGHAM ; N. SINGLETON ; R. SEDEFOV ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2018Captagon is reported to be a commonly used stimulant in the Middle East. In addition, some recent media reports have linked this drug to perpetrators of terrorist acts in Europe or terrorist groups based in areas of conflict in the Middle East. [...]
Article : Périodique
T. GROSHKOVA ; A. CUNNINGHAM ; L. ROYUELA ; N. SINGLETON ; T. SAGGERS ; R. SEDEFOV |Background: The importance of illicit drug price data and making appropriate adjustments for purity has been repeatedly highlighted for understanding illicit drug markets. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has [...]Nouveauté
Rapport
OEDT = EMCDDA ; I. GIRAUDON ; A. M. DINES ; N. SINGLETON ; A. NOOR ; P. I. DARGAN ; D. WOOD | Lisbon : OEDT / EMCDDA | Technical reports | 2020ENGLISH: This report presents the latest findings on drug-related hospital emergencies from a network of sentinel hospitals across Europe. Almost 24 000 emergency presentations were recorded at 32 sentinel hospitals over the first 4 years of th[...]Article : Périodique
Interventions to tackle the supply of drugs are seen as standard components of illicit drug policies. Therefore drug market-related administrative data, such as seizures, price, purity and drug-related offending, are used in most countries for p[...]
Périodique
A. BOYS ; M. FARRELL ; P. BEBBINGTON ; BRUGHA T. ; COID J. ; R. JENKINS ; G. LEWIS ; J. MARSDEN ; MELTZER H. ; N. SINGLETON ; C. TAYLOR | 2002FRANÇAIS : En Angleterre et au Pays de Galle, 3142 prisonniers ont été soumis à une enquête par questionnaire concernant leurs caractéristiques démographiques, leur trajectoire sociale, leurs problèmes psychiatriques et leurs consommations de d[...]Rapport
N. SINGLETON, Éditeur scientifique ; R. MURRAY, Éditeur scientifique ; L. TINSLEY, Éditeur scientifique | London : Home Office | Home Office Online Report | 2006Home Office Online Report 16/06 brings together the results of three studies which provide robust updated estimates of the size of the illegal drug use problem, from different perspectives. The new studies build on earlier studies but all contai[...]
Rapport
OEDT = EMCDDA ; L. VANDAM ; P. BORLE ; L. MONTANARI ; T. SURMONT ; A. PIRONA ; D. HEDRICH ; A. GALLEGOS ; N. SINGLETON ; J. MOUNTENEY ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2018This report looks at the use of new psychoactive substances (NPS) in prison settings. This is a rapidly developing phenomenon, but empirical data are currently scarce and patchy. There is growing evidence that NPS are responsible for a large sha[...]Article : Périodique
K. SKARUPOVA ; N. SINGLETON ; J. MATIAS ; V. MRAVCIK |Background: The European Web Survey on Drugs aimed to obtain in-depth data on consumption of cannabis, ecstasy/MDMA, cocaine, and amphetamines in different populations of drug users in 16 European countries. This paper examines test-retest relia[...]
Rapport
The proliferation of new psychoactive substances, or 'legal highs', in recent years has thrown the existing regulatory measures for drugs into sharp relief. As quickly as policy makers seek to control new substances through the Misuse of Drugs A[...]Article : Périodique
J. MATIAS ; E. KALAMARA ; F. MATHIS ; K. SKARUPOVA ; A. NOOR ; N. SINGLETON |Background: Most comparative drug policy analyses utilise measures of drug use, often from general population surveys (GPS). However, the limitations of GPS are well-recognised, including the small numbers of people who use illicit drugs sampled[...]
Rapport
OEDT = EMCDDA ; T. GROSHKOVA ; A. CUNNINGHAM ; N. SINGLETON ; T. STOIAN ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2019This paper describes open-source information monitoring and how we use it at the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in the area of drug markets - what it is and, importantly, what it is not; the methodology for its [...]Article : Périodique
Policy must move beyond evidence based to evidence infused to produce public good. In their foreword to the UK Home Office's comparison of drug policies in various countries, government ministers stated that "the UK will continue to advocate a [...]![Will the current COVID-19 pandemic impact on long-term cannabis buying practices? [Commentary]](https://bdoc.ofdt.fr/img_cache/018de63763106a86a33b48d9c51deb1c.png)
Article : Périodique
T. GROSHKOVA ; T. STOIAN ; A. CUNNINGHAM ; P. GRIFFITHS ; N. SINGLETON ; R. SEDEFOV |The COVID-19 pandemic and the response to have resulted in an increase in sales activity levels on darknet markets during the first 3 months of 2020, mainly related to cannabis products. One key question is whether more people will become used t[...]
